2m 2m 2m 2m 2m 2m 2m
BAUSCH HEALTH (BHC)
NYSE
$8.25-$0.11 (-1.26%)
Price as of Nov 12, 2026 8:35 AM EST- $3.1BMarket Cap
- 20.32%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BAUSCH HEALTH (BHC)
$8.25-$0.11 (-1.26%)
BHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.35 | ||
Change | +$0.06 (+0.72%) | ||
Open | $8.29 | ||
High | $8.46 | ||
Low | $8.20 | ||
Previous Close | $8.29 | ||
Volume | 2,401,051 | ||
30-Day Average Volume | 4,399,693 | ||
1-Week Change | 0.12% | ||
1-Month Change | 38.25% | ||
1-Year Change | 20.32% | ||
3-Year Change | 22.61% | ||
5-Year Change | -68.83% | ||
Fundamentals | |||
Shares Outstanding | 374.4M | ||
Total Assets | $25.5B | ||
Market Cap | $3.1B | ||
Enterprise Value | $21.3B | ||
Period: QTR TTM FY | |||
Revenue | $2.9B | ||
Net Income | $436.0M | ||
Free Cash Flow | $748.0M | ||
EBIT | $985.0M | ||
EBITDA | $1.3B | ||
Net Working Capital | $2.7B | ||
EPS | $1.15 | ||
Enterprise Value/EBITDA | 17 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -2 | ||
P/E | 7 | ||
PEG | 0 | ||
Price/Free Cash Flow | 4 | ||
Price/Operating Cash Flow | 4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/10/2010 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue